• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

最低点B细胞计数与卡波西肉瘤的风险显著相关。

Nadir B cell counts are significantly correlated with the risk of Kaposi's sarcoma.

作者信息

Stebbing Justin, Gazzard Brian, Newsom-Davis Tom, Nelson Mark, Patterson Steve, Gotch Frances, Mandalia Sundhiya, Bower Mark

机构信息

Department of Immunology, Division of Investigative Science, Faculty of Medicine, Imperial College of Science, Technology and Medicine, The Chelsea and Westminster Hospital, London, United Kingdom.

出版信息

Int J Cancer. 2004 Jan 20;108(3):473-4. doi: 10.1002/ijc.11601.

DOI:10.1002/ijc.11601
PMID:14648716
Abstract

Infection with HIV-1 is known to impair B cell function. To further elucidate the role of B cells during infection and tumorigenesis, we studied their numbers in cases of AIDS-related Kaposi's sarcoma (KS) during the HAART era. Patients with AIDS-related KS were identified from a database of 4,480 HIV-1 positive individuals and the incidence of KS and rate ratio was stratified according to nadir number of B cells, measured as the CD19 count. In an unadjusted model, we observed that lower B cell counts were associated with a statistically significant increased risk of KS development (p < 0.001). We also observed a trend toward increased counts during KS resolution. When adjusted for nadir CD4 count in a multi-variable model, higher B cell counts were protective against KS development (p = 0.015). These data highlight a potential role for B cells and therefore the humoral immune system in KS aetiopathogenesis.

摘要

已知感染HIV-1会损害B细胞功能。为了进一步阐明B细胞在感染和肿瘤发生过程中的作用,我们研究了高效抗逆转录病毒治疗(HAART)时代艾滋病相关卡波西肉瘤(KS)病例中B细胞的数量。从一个包含4480名HIV-1阳性个体的数据库中识别出艾滋病相关KS患者,并根据以CD19计数衡量的B细胞最低点数量对KS的发病率和率比进行分层。在一个未调整的模型中,我们观察到较低的B细胞计数与KS发生风险在统计学上显著增加相关(p < 0.001)。我们还观察到在KS消退期间计数有增加的趋势。在多变量模型中对最低点CD4计数进行调整后,较高的B细胞计数对KS发生有保护作用(p = 0.015)。这些数据突出了B细胞以及因此体液免疫系统在KS发病机制中的潜在作用。

相似文献

1
Nadir B cell counts are significantly correlated with the risk of Kaposi's sarcoma.最低点B细胞计数与卡波西肉瘤的风险显著相关。
Int J Cancer. 2004 Jan 20;108(3):473-4. doi: 10.1002/ijc.11601.
2
Seroreactivity to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent nuclear antigen in AIDS-associated Kaposi's sarcoma patients depends on CD4+ T-cell count.艾滋病相关卡波西肉瘤患者对卡波西肉瘤相关疱疹病毒(人疱疹病毒8型)潜伏核抗原的血清反应性取决于CD4+T细胞计数。
J Med Virol. 2007 Oct;79(10):1562-8. doi: 10.1002/jmv.20949.
3
Prognostic significance of immune subset measurement in individuals with AIDS-associated Kaposi's sarcoma.艾滋病相关卡波西肉瘤患者免疫亚群检测的预后意义
J Clin Oncol. 2007 Jun 1;25(16):2230-5. doi: 10.1200/JCO.2007.10.7219. Epub 2007 Apr 30.
4
Interleukin 6 and AIDS-associated Kaposi's sarcoma: a nested case control study within the Multicenter AIDS Cohort Study.白细胞介素6与艾滋病相关卡波西肉瘤:多中心艾滋病队列研究中的一项巢式病例对照研究
AIDS Res Hum Retroviruses. 1997 Jun 10;13(9):781-8. doi: 10.1089/aid.1997.13.781.
5
Isolated penile Kaposi's sarcoma in a HIV-positive patient stable on treatment for three years.一名接受治疗三年病情稳定的HIV阳性患者出现孤立性阴茎卡波西肉瘤。
Int J STD AIDS. 2014 Jul;25(8):607-10. doi: 10.1177/0956462413517494. Epub 2014 Feb 3.
6
Fatal Disseminated Kaposi's Sarcoma in Two Patients with Human Immunodeficiency Virus (HIV) Infection.两名人类免疫缺陷病毒(HIV)感染者发生致命性播散性卡波西肉瘤
Am J Case Rep. 2018 Jul 25;19:868-874. doi: 10.12659/AJCR.910004.
7
Kaposi's sarcoma in HIV infected women in Germany: more evidence for sexual transmission. A report of 10 cases and review of the literature.德国HIV感染女性中的卡波西肉瘤:性传播的更多证据。10例报告及文献综述。
Genitourin Med. 1994 Dec;70(6):394-8. doi: 10.1136/sti.70.6.394.
8
A comparison of regimens based on non-nucleoside reverse transcriptase inhibitors or protease inhibitors in preventing Kaposi's sarcoma.基于非核苷类逆转录酶抑制剂或蛋白酶抑制剂的方案在预防卡波西肉瘤方面的比较。
AIDS. 2003 Jul 25;17(11):F17-22. doi: 10.1097/00002030-200307250-00001.
9
[Immune activation in AIDS related Kaposi's sarcoma].[艾滋病相关卡波西肉瘤中的免疫激活]
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2003 Apr;32(2):101-3. doi: 10.3785/j.issn.1008-9292.2003.02.005.
10
Retrospective, longitudinal analysis of serum human herpesvirus-8 viral DNA load in AIDS-related Kaposi's sarcoma patients before and after diagnosis.对艾滋病相关卡波西肉瘤患者诊断前后血清人疱疹病毒8型病毒DNA载量进行回顾性纵向分析。
J Med Virol. 2004 Nov;74(3):390-6. doi: 10.1002/jmv.20192.

引用本文的文献

1
Clinical Efficacy of the HIV Protease Inhibitor Indinavir in Combination with Chemotherapy for Advanced Classic Kaposi Sarcoma Treatment: A Single-Arm, Phase II Trial in the Elderly.晚期经典型卡波西肉瘤治疗中 HIV 蛋白酶抑制剂茚地那韦联合化疗的临床疗效:一项在老年人中进行的单臂、Ⅱ期试验。
Cancer Res Commun. 2024 Aug 1;4(8):2112-2122. doi: 10.1158/2767-9764.CRC-24-0102.
2
Rituximab-Induced Kaposi Sarcoma in HIV-Negative Patients: A Narrative Review.利妥昔单抗诱导的HIV阴性患者卡波西肉瘤:一项叙述性综述。
Cureus. 2023 Sep 16;15(9):e45365. doi: 10.7759/cureus.45365. eCollection 2023 Sep.
3
Reversible rituximab-induced rectal Kaposi's sarcoma misdiagnosed as ulcerative colitis in a patient with HIV-negative follicular lymphoma.
一名HIV阴性滤泡性淋巴瘤患者中,利妥昔单抗诱导的可逆性直肠卡波西肉瘤被误诊为溃疡性结肠炎。
Clin Sarcoma Res. 2018 Jun 11;8:11. doi: 10.1186/s13569-018-0097-7. eCollection 2018.
4
Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman disease.利妥昔单抗联合脂质体阿霉素治疗合并卡波西肉瘤相关多中心Castleman病的HIV感染患者。
Blood. 2014 Dec 4;124(24):3544-52. doi: 10.1182/blood-2014-07-586800. Epub 2014 Oct 20.
5
Castleman disease.卡斯尔曼病
Korean J Hematol. 2012 Sep;47(3):163-77. doi: 10.5045/kjh.2012.47.3.163. Epub 2012 Sep 25.
6
Recent advances in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.卡波西肉瘤疱疹病毒相关多中心 Castleman 病的最新进展。
Curr Opin Oncol. 2012 Sep;24(5):495-505. doi: 10.1097/CCO.0b013e328355e0f3.
7
Update on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi Sarcoma.卡波西肉瘤的流行病学、发病机制和治疗的最新进展。
Cancer Lett. 2011 Jun 28;305(2):150-62. doi: 10.1016/j.canlet.2011.02.006. Epub 2011 Mar 4.
8
Development of Kaposi's sarcoma after complete remission of multicentric Castlemans disease with rituximab therapy in a HHV8-positive, HIV-negative patient.在一名HHV8阳性、HIV阴性患者中,利妥昔单抗治疗使多中心Castleman病完全缓解后发生卡波西肉瘤。
Int J Hematol. 2010 Mar;91(2):347-8; author reply 349. doi: 10.1007/s12185-010-0497-9. Epub 2010 Feb 10.
9
Pathology of rituximab-induced Kaposi sarcoma flare.利妥昔单抗诱导的卡波西肉瘤发作的病理学
BMC Clin Pathol. 2008 Jul 23;8:7. doi: 10.1186/1472-6890-8-7.
10
Highly active anti-retroviral therapy (HAART)-induced maintenance of adaptive but not innate immune parameters is associated with protection from HIV-induced mortality.高效抗逆转录病毒疗法(HAART)诱导的适应性而非先天性免疫参数的维持与预防HIV诱导的死亡相关。
Clin Exp Immunol. 2006 Aug;145(2):271-6. doi: 10.1111/j.1365-2249.2006.03147.x.